Table of Contents: CATIE TreatmentUpdate - 2003


Canadian AIDS Treatment Information Exchange
Edited by: Sean Hosein

Table Of Contents

TreatmentUpdate 139: November/December - Vol. 15, No. 7
ANTI-HIV AGENTS: A warning about high viral loads; ANTI-HIV AGENTS: Dying without ever having received treatment in Canada; ANTI-HIV AGENTS: Study finds recovery of CD4+ cells may be less than expected; INFECTION FIGHTERS: Valtrex suppresses herpes outbreaks; INFECTION FIGHTERS: High-dose Valtrex for oral hairy leukoplakia

TreatmentUpdate 138: October - Vol. 15, No. 6
ANTI-HIV AGENTS: Introduction to ICAAC: Selected highlights from the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Trying times for tenofovir and abacavir; Abacavir—as good as AZT?, Abacavir only once-daily; Who gets abacavir allergies?; High-dose vitamin C may affect indinavir users; NUTRITION: Study finds vitamin B12 levels low in some HAART users

TreatmentUpdate 137: August/September - Vol. 15, No. 5
ANTI-HIV AGENTS: The future of drug therapy; How long will a first regimen last?; Alternating regimens look promising; Drug holidays; An attempt at treatment interruption; Can immune boosters prolong the time away from HAART?

TreatmentUpdate 136: June/July - Vol. 15, No. 4
ANTI-HIV AGENTS: Atazanavir as a booster for protease inhibitors; IMMUNE BOOSTERS: Murabutide - debut of a new immune booster?; NUTRITION: Complementary therapies in Ontario; ANTI-CANCER AGENTS: Unique protocol looks promising for lymphoma

TreatmentUpdate 135: April/May - Vol. 15, No. 3
Introduction; Nevirapine levels in the blood found higher in women; Efavirenz levels in the blood found higher in women; Drinking lots of water still necessary with new indinavir regimens; Monitoring levels of non-nukes considered important by some doctors; Checking up on ddI and tenofovir in PHAs; Drug levels in PHAs who receive liver transplants; Atazanavir — the booster of the future?; New formulation of nelfinavir on the way; Does Roche's nelfinavir cause less diarrhea?

TreatmentUpdate 134: February/March - Vol. 15, No. 2
Introduction; Anti-HIV Agents: New Drugs in the pipeline; Anti-HIV Agents: Nevirapine found to be as effective as Efavirenz; Anti-HIV Agents: Tenofovir — long-term results from first-line therapy; Anti-HIV Agents: Kidney damage reported in some Tenofovir users; Anti- HIV Agents: Tenofovir drug interactions: DDI and D4T; Anti-HIV Agents: A nuke-free regimen

TreatmentUpdate 133: January - Vol. 15, No. 1
BODY PARTS: Get hip on bone health; BODY PARTS: Batting an eye at HIV; INFECTION FIGHTERS: Tenofovir helps beat hepatitis B; NUTRITION: Fighting heart disease with fish?; ANTI-CANCER AGENTS: Antibody therapy zaps cancer; ANTI-CANCER AGENTS: Does HAART affect anal growths?

Copyright / Staff / How to Contact
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,2003. AEGiS . All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS , or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.